121 0 Kommentare Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease

Aim is to prevent avoidable heart attacks and strokes in North London
Expands primary care capacity by utilising digital tools to identify and manage high risk individuals
Advances proactive, predictive care for people at risk of the world's leading cause of death¹

LONDON, Feb. 8, 2023 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leading global digital health company, today announced a partnership with Camden Health Partners and UCLPartners to deliver a digital-first programme aimed at identifying more people living in North Central London who are at high risk of, or who have undiagnosed, cardiovascular disease (CVD) and helping them to adopt new behaviours to help modify the condition. The programme will form a blueprint for potential national adoption.

Supported by a grant from the Small Business Research Initiative (SBRI) Healthcare, the initiative aligns with the government's review-driven² plans to digitise the existing National Health Service (NHS) Health Check, making it more convenient for patients to carry out the checks at home and reduce pressure on GPs³.

People at risk of, or with, CVD are typically identified during an NHS Health Check. These checks require considerable face-to-face healthcare resources, and some remain incomplete because individuals do not follow through with appointments to measure biomarkers such as blood tests. The digital-first programme aims to expand the Health Check system by:

prompting individuals to complete appointments linked to the Health Check through Huma's iPLATO multi-channel engagement platform
moving the majority of the Health Check to a digital format on Huma's remote patient monitoring platform, reducing in-person appointment duration and thereby increasing population screening capacity
driving access to online, approved materials which recommend lifestyle changes in line with improving CVD status
providing enhanced access to face-to-face health checks for those who do not wish to use digital tools, to avoid digital exclusion

Dan Vahdat, CEO and Founder of Huma, said "We are proud to be part of the global movement that is bringing health equity through digital technology to people everywhere. Imagine the impact we could make by reaching tens of thousands of people across London alone who may be at risk of cardiovascular disease, making them aware of cardiovascular health, helping educate them and encouraging them to connect with their clinicians. This is the very definition of proactive care and I am so excited that, together with our clinical partners, we have the opportunity to scale our evidence-based digital innovations to advance personalised health."